SFB Seminar: Prof. Atan Gross

Zeit : Donnerstag , 16:30 - 17:30
Ort : Room 2609/10 (Medical Building),

Speaker:  Atan Gross
Weizmann Institute
Rehovot, Israel
Topic:  The ATM-BID-MITCH2 pathway regulates haematopoietic stem cell fate by controlling mitochondria metabolism
Host:  Hans-Jörg Fehling

Prof. Gross earned his PhD at the Hebrew University in Jerusalem, performed his Postdoctoral studies at the Dana Farber Cancer Institute in Boston, and joined the Department of Biological Regulation at the Weizmann Institute in 2000. The major research topics of the Gross lab evolve around how mitochondria act as “headquarters” to coordinate metabolism and apoptosis and the relevance to disease.